Acadia Pharmaceuticals ACAD Increase Decrease In Operating Lease Assets
Increase Decrease In Operating Lease Assets at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept acad:IncreaseDecreaseInOperatingLeaseAssets.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's increase decrease in operating lease assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's increase decrease in operating lease assets?
- Acadia Pharmaceuticals (ACAD) reported increase decrease in operating lease assets of -$2.16M in Q1 2026.
- How has Acadia Pharmaceuticals's increase decrease in operating lease assets changed year-over-year?
- Acadia Pharmaceuticals's increase decrease in operating lease assets decreased by 1.3% year-over-year, from -$2.14M to -$2.16M.
- What is the long-term trend for Acadia Pharmaceuticals's increase decrease in operating lease assets?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's increase decrease in operating lease assets has grown at a 8.4% compound annual growth rate (CAGR), from -$6.29M to -$8.67M.
- What does increase decrease in operating lease assets mean?
- This reflects the change in the carrying value of right-of-use assets recognized under operating lease agreements. An increase indicates the acquisition or renewal of lease assets, while a decrease represents amortization or impairment of these assets. It is a critical component for understanding the company's commitment to long-term operational infrastructure and its impact on cash flow.